DocGo Inc. (NASDAQ: DCGO) Q2 2026 Earnings: Mobile Health Provider's Financial Performance Analysis

• DocGo Inc. (NASDAQ: DCGO) reported Q2 2026 EPS of -$0.10, narrowly missing analyst estimates, while revenue reached $75.58 million, surpassing expectations.
• Despite a year-over-year revenue decline due to migrant program wind-downs, DocGo demonstrates a robust financial structure with a low debt-to-equity ratio of 0.22 and a healthy current ratio of 1.66.
• Canaccord Genuity maintains a Hold rating for DocGo, adjusting its price target to $1.00.

DocGo Inc. (NASDAQ: DCGO) is a company that provides mobile health services and medical transportation using technology. On August 17, 2026, the company announced its financial results for the second quarter. These results provide insight into DocGo's recent performance and financial standing.

On its earnings, DocGo reported earnings per share (EPS) of -$0.10. This figure narrowly missed the market's consensus estimate of -$0.097. The company's negative EPS is reflected in its price-to-earnings (P/E) ratio of -0.36, which indicates DocGo has experienced a net loss over the past year.

For the same quarter, DocGo's revenue came in at $75.58 million. This result successfully beat the analyst expectation of $75.35 million. However, this revenue figure shows a decrease compared to the $80.40 million reported in the same quarter of the previous year.

The decline in year-over-year revenue is primarily due to the wind-down of migrant-related programs, as highlighted by Business Wire. Despite this, DocGo's financial structure shows a low debt-to-equity ratio of 0.22. This means it relies more on its own funds rather than borrowing to finance its operations.

DocGo maintains a current ratio of 1.66, which suggests it has enough current assets to meet its short-term obligations. Regarding analyst views, as highlighted by Benzinga, Canaccord Genuity maintains a Hold rating on the stock, adjusting its price target to $1.00.